Hilkka Soininen
Hilkka Soininen is an expert in Neurology at Kuopio University Hospital (Finland). As of October 2026, ScienceLeadR ranks Hilkka Soininen in the top 1% of experts worldwide for Alzheimer Disease, Cognition Disorders and Dementia. Hilkka Soininen has authored 1,099 publications, the most recent in 2026, and is an investigator in 8 clinical trials. SLR score: 2,949 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Genetics - Geriatrics - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 1099
Citations
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Population-scale immune multiome atlas reveals regulatory disease mechanisms. PMID 42816628 — cells, genes, chromatin | Nature Top journal | 2026 | 0 |
| PLCG2 downregulation impairs synaptic function and increases Alzheimer's disease hallmarks in neuronal cultures. PMID 42601455 — neurons, alzheimer disease, down-regulation, genetics, medical | Nat Genet | 2026 | 1 |
| XXYLT1 and Mendelian Retinal Dystrophy. PMID 42530953 — retinal dystrophies, genes, genome, eye diseases, retinaldehyde | JAMA Ophthalmol | 2026 | 0 |
| Association and risk prediction of 19 complex diseases with polygenic scores and socioeconomic status. PMID 42277436 — genetic predisposition to disease, occupations, education | Commun Med (Lond) | 2026 | 0 |
| Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias. PMID 42237039 — dementia, alzheimer disease, pathology, genome-wide association study, genome | Nat Genet | 2026 | 8 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 9
LeadR Networks
Main global connection map